ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1

Xiang, Wenjing; Yang, Yang; Weng, Liangkun; Ye, Zhiming; Ding, Ping; Li, Huayu; Sun, Jia; Zeng, Cheng*广东药学院; 1
International Immunopharmacology2023-5DOI: 10.1016/j.intimp.2023.110085
2被引6阅读
引用收藏
分享

摘要

Hyperhomocysteinemia (HHcy) is associated with nonalcoholic fatty liver disease (NAFLD) and insulin resistance (IR). However, the underlying mechanism is still unknown. Recent studies have demonstrated that NLRP3 inflammasome activation plays a vital role in NAFLD and IR. Our study aimed to explore whether NLRP3 inflammasome contributed to HHcy-induced NAFLD and IR as well as dissected the underlying mechanism. C57BL/6 mice were fed a high-methionine diet (HMD) for 8 weeks to establish the HHcy mouse model. Compared with a chow diet, HMD induced hepatic steatosis (HS) and IR as well as activation of hepatic NLRP3 inflammasome. Moreover, HHcy-induced NAFLD and IR characterization disclosed that NLRP3 inflammasome activation occurred in liver tissue of HMD-fed mice, but was very marginal in either NLRP3-/- or Caspase-1-/- mice. Mechanistically, high levels of homocysteine (Hcy) up-regulated the expression of mouse double minute 2 homolog (MDM2), which directly ubiquitinates heat shock transcription factor 1 (HSF1) and consequently activated hepatic NLRP3 inflammasome in vivo and in vitro. In addition, in vitro experiments showed P300 -mediated HSF1 acetylation at K298 hindered MDM2-mediated ubiquitination of HSF1 at K372, which plays important role in determining the HSF1 level. Importantly, either inhibition of MDM2 by JNJ-165 or activation of HSF1 by HSF1A reversed HMD-induced hepatic NLRP3 inflammasome, and consequently alleviated HS and IR in mice. This study demonstrates that NLRP3 inflammasome activation contributes to HHcy-induced NAFLD and IR, and further identified that HSF1 as a new substrate of MDM2 and its decrease on MDM2-mediated ubiq-uitination at K372 modulates NLRP3 inflammasome activation. These findings may provide novel therapeutic strategies aimed at halting HS or IR.

学科与关键词

关键词
HyperhomocysteinemiaNLRP3 inflammasomeHSF1MDM2Nonalcoholic fatty liver diseaseInsulin resistance
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2023-05
卷期
第 118 卷
页码
110085
DOI
10.1016/j.intimp.2023.110085
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82100379]; Guangzhou Science and Technology Project [202201010148]; Guangdong Provincial Medical Research Fund Project in 2021 [A2021120]; National Key Clinical Specialty Construction Project (Clinical Pharmacy); High-Level Clinical Key Specialty (Clinical Pharmacy) in Guangdong Province

作者

  • X

    Xiang, Wenjing (第一作者)

    guangdong pharmaceut univ

  • Y

    Yang, Yang

    zhuhai peoples hosp

查看全部 8 位作者收起作者
  • W

    Weng, Liangkun

    guangdong pharmaceut univ

  • Y

    Ye, Zhiming

    guangdong pharmaceut univ

  • D

    Ding, Ping

    guangdong pharmaceut univ

  • L

    Li, Huayu

    guangdong pharmaceut univ

  • S

    Sun, Jia

    guangdong pharmaceut univ

  • Z

    Zeng, Cheng (通讯)

    1 · guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417